Enhance your MRD detection capabilities for AML

Introducing the SureSeq Myeloid MRD Panel

• Don’t miss key genomic insights: Detect key variants across 45 hotspot exons in 13 key AML-associated genes (including longer, ultra-low frequency FLT3-ITDs) for the clearest picture of your sample’s MRD status
• Ultra-low variant detection down to 0.05% VAF: Confidently detect MRD with SureSeq’s unparalleled bait design and sequence identification strategy for sensitive detection, including for key targets like NPM1
• Personalize your workflow: Choose between two workflow options to tailor your approach for your sensitivity, sample batching and sequencing requirements
• Get the most out of your MRD data: Our complimentary analysis software, Interpret, gets you started with an ‘out of the box’ bioinformatic analysis pipeline without adding to your lab’s bioinformatics burden

For more detailed information, including detailed information on product specifications and performance, please visit our product web page